Stockscreener 앱 받기
0.5501
2.05%
-0.0115
시간 외 거래:
.56
0.0099
+1.80%
전일 마감가:
$0.5616
열려 있는:
$0.545
하루 거래량:
5.50M
Relative Volume:
1.07
시가총액:
$165.97M
수익:
$52.29M
순이익/손실:
$-134.84M
주가수익비율:
-0.7335
EPS:
-0.75
순현금흐름:
$-117.11M
1주 성능:
-5.16%
1개월 성능:
-19.45%
6개월 성능:
-23.60%
1년 성능:
-74.53%
1일 변동 폭
$0.5341
$0.5607
1주일 범위
$0.5341
$0.6219
52주 변동 폭
$0.4111
$3.179
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
명칭
Sangamo Therapeutics Inc
전화
(510) 970-6000
주소
501 CANAL BLVD., RICHMOND, CA
SGMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGMO
Sangamo Therapeutics Inc
|
0.5501 | 169.44M | 52.29M | -134.84M | -117.11M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.00 | 107.10B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.19 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.56 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
832.35 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.88 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 업그레이드 | Truist | Hold → Buy |
| 2024-12-10 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-04-28 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-02-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-06-13 | 재개 | Wedbush | Neutral |
| 2021-05-04 | 개시 | RBC Capital Mkts | Outperform |
| 2021-01-07 | 재개 | Guggenheim | Neutral |
| 2021-01-06 | 개시 | Stifel | Hold |
| 2020-12-16 | 재개 | H.C. Wainwright | Buy |
| 2020-09-08 | 개시 | BofA Securities | Buy |
| 2020-07-07 | 개시 | SunTrust | Buy |
| 2019-08-26 | 개시 | H.C. Wainwright | Buy |
| 2018-11-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-06-20 | 개시 | BofA/Merrill | Buy |
| 2017-11-15 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-06-22 | 재개 | Jefferies | Buy |
| 2016-11-01 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-10-19 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2015-12-04 | 개시 | Wells Fargo | Outperform |
| 2015-10-23 | 재개 | Jefferies | Buy |
| 2013-05-03 | 개시 | BioLogic Equity Research | Sell |
| 2011-02-23 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-07-29 | 재확인 | Wedbush | Outperform |
| 2009-10-19 | 개시 | Brean Murray | Sell |
| 2009-10-07 | 재확인 | Leerink Swann | Outperform |
| 2009-08-25 | 재확인 | JMP Securities | Mkt Outperform |
모두보기
Sangamo Therapeutics Inc 주식(SGMO)의 최신 뉴스
Can Sangamo Therapeutics Inc. stock outperform in 2025 bull market2025 Technical Overview & Weekly High Return Forecasts - newser.com
Sangamo Therapeutics : ST-506 mediates brainwide lowering of prion protein in nonhuman primates via a conserved blood-brain-barrier crossing mechanism, as a potential one-time treatment for prion disease - MarketScreener
Can Sangamo Therapeutics Inc. stock sustain revenue growthEntry Point & Precise Swing Trade Alerts - fcp.pa.gov.br
Sangamo Therapeutics (SGMO) to Release Quarterly Earnings on Tuesday - MarketBeat
Will Sangamo Therapeutics Inc. stock maintain growth storyEarnings Recap Summary & Real-Time Price Movement Reports - fcp.pa.gov.br
Sangamo Therapeutics Inc. stock chart pattern explained2025 Market Overview & Verified High Yield Trade Plans - newser.com
Using AI based signals to follow Sangamo Therapeutics Inc.Trade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Will Sangamo Therapeutics Inc. stock outperform Nasdaq indexTrade Exit Report & Technical Entry and Exit Alerts - newser.com
Why retail investors favor Sangamo Therapeutics Inc. stock2025 EndofYear Setup & AI Driven Stock Movement Reports - newser.com
Is Sangamo Therapeutics Inc. stock a safe haven assetTrade Analysis Summary & Short-Term High Return Strategies - newser.com
Is Sangamo Therapeutics Inc. stock in correction or buying zone2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Detecting price anomalies in Sangamo Therapeutics Inc. with AIRate Hike & Safe Capital Growth Trade Ideas - newser.com
How hedge fund analytics apply to Sangamo Therapeutics Inc. stockTake Profit & Weekly Breakout Watchlists - newser.com
Sangamo Therapeutics Inc expected to post breakeven results a shareEarnings Preview - TradingView
Tick level data insight on Sangamo Therapeutics Inc. volatility2025 Market WrapUp & Precise Buy Zone Identification - newser.com
Published on: 2025-11-04 04:55:19 - newser.com
Why analysts recommend Sangamo Therapeutics Inc. (GBY) stock2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
How buybacks impact Sangamo Therapeutics Inc. stock value2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
What analysts say about Sangamo Therapeutics Inc GBY stockMarket Entry Points & Free Extraordinary Earning Power - earlytimes.in
Real time pattern detection on Sangamo Therapeutics Inc. stockTreasury Yields & Long-Term Growth Plans - newser.com
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call - Zenopa
How Sangamo Therapeutics Inc. stock reacts to bond yieldsEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com
What analyst consensus says on Sangamo Therapeutics Inc. stock2025 Pullback Review & Verified Momentum Watchlists - newser.com
What machine learning models say about Sangamo Therapeutics Inc.Profit Target & AI Based Trade Execution Alerts - newser.com
How Sangamo Therapeutics Inc. (GBY) stock reacts to monetary easingJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Sangamo Therapeutics Inc (SGMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.82%
1.34%
자본화:
|
볼륨(24시간):